Skip to main content

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

Correction to: Health Economics Review (2019) 9:22

https://doi.org/10.1186/s13561-019-0237-7

Following publication of the original article [1], the authors reported that one of the numbers within Fig. 6 contains a mistake.

The correct Fig. 6 is shown below.

Fig. 6
figure1

Expected cost of treatment of the different strategies for SBP

Reference

  1. 1.

    Runken, et al. The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain. Health Economics Review. 2019;9:22. https://doi.org/10.1186/s13561-019-0237-7.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Rashad Carlton.

Additional information

The original article can be found online at https://doi.org/10.1186/s13561-019-0237-7

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Runken, M.C., Caraceni, P., Fernandez, J. et al. Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain. Health Econ Rev 10, 8 (2020). https://doi.org/10.1186/s13561-020-00265-0

Download citation